arrow
S

Solmaz Sahebjam

Johns Hopkins University School of Medicine
H指数:36
被引数:6,004

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RMTC-10 DEFINING SYMPTOMATIC VERSUS ASYMPTOMATIC BRAIN METASTASES FOR CLINICAL TRIAL ELIGIBILITY: A DELPHI CONSENSUS INITIATIVE

RMTC-10 定义有症状与无症状脑转移用于临床试验入组资格:一项德尔菲共识倡议

2026-08-070
OA
Unique Peritumoral Patterns Unveiled by Quantitative Multiparametric MRI and Their Diagnostic and Prognostic Value in Treated Malignant Gliomas

定量多参数MRI揭示的独特肿瘤周模式及其在治疗性恶性胶质瘤中的诊断和预后价值

2026-04-190
PRE
BIOM-56. A FEASIBILITY STUDY UTILIZING SEQUENTIAL CEREBROSPINAL FLUID (CSF) - BASED LIQUID BIOPSY AND AMIDE PROTON TRANSFER (APT) MRI TO DIFFERENTIATE DISEASE PROGRESSION FROM RADIATION NECROSIS IN PATIENTS WITH BRAIN METASTASIS FROM SOLID TUMORS

BIOM-56. 一项利用序贯脑脊液(CSF)为基础的液体活检和酰胺质子转移(APT) MRI来区分疾病进展与放射性坏死的可行性研究,用于来自实体瘤的脑转移患者。

2025-11-010
OAAI
Implementing a centralized, institution-wide neuro-oncology database to advance precision neuro-oncology and multidisciplinary research

实施一个集中化、覆盖全机构的神经肿瘤学数据库,以推动精准神经肿瘤学和多学科研究

2025-11-010
OAAI
Intracranial metastases from solid tumors: Call to action and consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology collaborative

颅内转移瘤:神经肿瘤学会和临床肿瘤学会协作的呼吁与共识

2025-10-060
OAAI
Phase IB study of Avelumab and whole brain radiotherapy in patients with leptomeningeal disease from solid tumors: Results and molecular analyses

Avelumab联合全脑放射疗法治疗实体瘤所致软脑膜疾病的IB期研究:结果与分子分析

2025-10-010
OAAI
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024

脑转移瘤在非小细胞肺癌中的患病率、治疗方法和生存率:一项基于2014年至2024年多机构理赔数据的回顾性研究

2025-07-210
PRE
Incidence, demographics, and survival of patients with brain metastases from stage IV colorectal cancer: a population-based study from 2013 to 2023

脑转移瘤的发病率、人口统计学特征及生存情况:一项基于人群的研究(2013年至2023年)

2025-07-210
PRE
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

静脉免疫球蛋白(IVIG)用于与嵌合抗原受体T细胞(CAR-T)疗法相关的严重神经毒性患者

2025-04-210
OA
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas
2025-02-080
OAAI
Testing neuro-oncology tenets: are MRI findings and symptoms different with true progression compared with immunotherapy-related treatment effect in patients with primary brain tumors?
2024-03-040
PRE